Literature DB >> 20237137

Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study.

Pawel Szulc1, Françoise Munoz, François Marchand, Roland Chapurlat, Pierre D Delmas.   

Abstract

BACKGROUND: Changes in body composition underlying the association between weight loss and higher mortality are not clear.
OBJECTIVE: The objective was to investigate the association between changes in body composition of the appendicular (4 limbs) and central (trunk) compartments and all-cause mortality in men.
DESIGN: In men aged > or = 50 y, body composition was assessed every 18 mo for 7.5 y with a whole-body dual-energy X-ray absorptiometry scan. Mortality was assessed for 10 y. Data were analyzed by logistic regression and Cox model and adjusted for age, body mass index (BMI), educational level, lifestyle, physical performance, comorbidities, body composition, and serum concentrations of 17beta-estradiol and 25-hydroxycholecalciferol.
RESULTS: Of 715 men who were followed up, 137 (19.2%) died. Mortality was higher in men with the fastest weight loss [lowest compared with middle tertile odds ratio (OR): 2.31; 99% CI: 1.05, 5.09]. Faster loss of appendicular skeletal muscle mass (ASMM) was predictive of mortality (lowest compared with middle tertile OR: 3.60; 99% CI: 1.64, 7.89). Faster loss in ASMM remained a strong predictor of mortality after adjustment for weight loss (OR: 3.41; 99% CI: 1.51, 7.71). Faster loss in ASMM was the strongest predictor of death in the stepwise procedures when it was analyzed jointly with changes in the mass of other compartments. Loss in ASMM calculated over 36 mo was also a stronger predictor of death than were changes in the mass of other compartments (hazard ratio: 1.33 per 1-SD decrease; 95% CI: 1.06, 1.66).
CONCLUSION: The accelerated loss of ASMM is predictive of all-cause mortality in older men regardless of age, BMI, lifestyle, physical performance, health status, body composition, and serum 17beta-estradiol and 25-hydroxycholecalciferol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237137     DOI: 10.3945/ajcn.2009.28256

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  40 in total

1.  Ribosome biogenesis may augment resistance training-induced myofiber hypertrophy and is required for myotube growth in vitro.

Authors:  Michael J Stec; Neil A Kelly; Gina M Many; Samuel T Windham; S Craig Tuggle; Marcas M Bamman
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-09       Impact factor: 4.310

2.  Body composition, anthropometrics, energy expenditure, systemic inflammation, in premenopausal women 1 year after laparoscopic Roux-en-Y gastric bypass.

Authors:  Antonio Iannelli; Francesco Martini; Anty Rodolphe; Anne-Sophie Schneck; Philippe Gual; Albert Tran; Xavier Hébuterne; Jean Gugenheim
Journal:  Surg Endosc       Date:  2013-09-07       Impact factor: 4.584

3.  Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.

Authors:  Rebecca Scherzer; Steven B Heymsfield; Daniel Lee; William G Powderly; Phyllis C Tien; Peter Bacchetti; Michael G Shlipak; Carl Grunfeld
Journal:  AIDS       Date:  2011-07-17       Impact factor: 4.177

4.  Regrowth after skeletal muscle atrophy is impaired in aged rats, despite similar responses in signaling pathways.

Authors:  Jena R White; Amy L Confides; Stephanie Moore-Reed; Johanna M Hoch; Esther E Dupont-Versteegden
Journal:  Exp Gerontol       Date:  2015-02-12       Impact factor: 4.032

5.  Lean mass declines consistently over 10 years in people living with HIV on antiretroviral therapy, with patterns differing by sex.

Authors:  Paula Debroy; Jordan E Lake; Myung Sim; Kristine M Erlandson; Julian Falutz; Carla M Prado; Todd T Brown; Giovanni Guaraldi; The Modena Hiv Metabolic Cohort Team
Journal:  Antivir Ther       Date:  2019

6.  Label-free quantitative protein profiling of vastus lateralis muscle during human aging.

Authors:  Laëtitia Théron; Marine Gueugneau; Cécile Coudy; Didier Viala; Astrid Bijlsma; Gillian Butler-Browne; Andrea Maier; Daniel Béchet; Christophe Chambon
Journal:  Mol Cell Proteomics       Date:  2013-11-11       Impact factor: 5.911

7.  Longitudinal assessment of physical activity in women undergoing Roux-en-Y gastric bypass.

Authors:  Daniel Berglind; Mikaela Willmer; Ulf Eriksson; Anders Thorell; Magnus Sundbom; Joanna Uddén; Mustafa Raoof; Jakob Hedberg; Per Tynelius; Erik Näslund; Finn Rasmussen
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

8.  Accelerometer-Measured Versus Self-Reported Physical Activity Levels and Sedentary Behavior in Women Before and 9 Months After Roux-en-Y Gastric Bypass.

Authors:  Daniel Berglind; Mikaela Willmer; Per Tynelius; Ata Ghaderi; Erik Näslund; Finn Rasmussen
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

Review 9.  Optimal management of sarcopenia.

Authors:  Louise A Burton; Deepa Sumukadas
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

10.  A trial assessing N-3 as treatment for injury-induced cachexia (ATLANTIC trial): does a moderate dose fish oil intervention improve outcomes in older adults recovering from hip fracture?

Authors:  Michelle D Miller; Alison Yaxley; Anthony Villani; Lynne Cobiac; Robert Fraser; Leslie Cleland; Michael James; Maria Crotty
Journal:  BMC Geriatr       Date:  2010-10-22       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.